Drug Trial Radar · NCT00066742
Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
Last checked: Nov 19, 2026Latest source record: May 15, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
Sep 2003
Primary completion
Aug 2009
Study completion Aug 2009
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Aug 7, 2003
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial is studying how well giving tirapazamine together with cisplatin, etoposide, and radiation therapy works in treating patients with limited-stage small cell lung cancer. Drugs used in chemotherapy, such as cisplatin and etoposide, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Tirapazamine may make the tumor cells more sensitive to chemotherapy and radiation therapy. Combining chemotherapy and radiation therapy with tirapazamine may kill more tumor cells.
Conditions
- Limited Stage Small Cell Lung Cancer
Interventions
tirapazamineDrug
Given IV
cisplatinDrug
Given IV
etoposideDrug
Given IV
radiation therapyRadiation
Undergo radiation therapy
laboratory biomarker analysisOther
Correlative studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: Weekly during protocol treatment, then every 3 months for first year, then every 6 months for up to 3 years after enrollment.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Southwest Oncology Group (SWOG) Research Base
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.